Mechanism of activation of human heparanase investigated by protein engineering - PubMed (original) (raw)
. 2004 Feb 24;43(7):1862-73.
doi: 10.1021/bi030203a.
Affiliations
- PMID: 14967027
- DOI: 10.1021/bi030203a
Mechanism of activation of human heparanase investigated by protein engineering
Caterina Nardella et al. Biochemistry. 2004.
Abstract
The aim of this study was to investigate the mechanism of activation of human heparanase, a key player in heparan sulfate degradation, thought to be involved in normal and pathologic cell migration processes. Active heparanase arises as a product of a series of proteolytic processing events. Upon removal of the signal peptide, the resulting, poorly active 65 kDa species undergoes the excision of an intervening 6 kDa fragment generating an 8 kDa polypeptide and a 50 kDa polypeptide, forming the fully active heterodimer. By engineering of tobacco etch virus protease cleavage sites at the N- and C-terminal junctions of the 6 kDa fragment, we were able to reproduce the proteolytic activation of heparanase in vitro using purified components, showing that cleavage at both sites leads to activation in the absence of additional factors. On the basis of multiple-sequence alignment of the N-terminal fragment, we conclude that the first beta/alpha/beta element of the postulated TIM barrel fold is contributed by the 8 kDa subunit and that the excised 6 kDa fragment connects the second beta-strand and the second alpha-helix of the barrel. Substituting the 6 kDa fragment with the topologically equivalent loop from Hirudinaria manillensis hyaluronidase or connecting the 8 and 50 kDa fragments with a spacer of three glycine-serine pairs resulted in constitutively active, single-chain heparanases which were comparable to the processed, heterodimeric enzyme with regard to specific activity, chromatographic profile of hydrolysis products, complete inhibition at NaCl concentrations above 600 mM, a pH optimum of pH approximately 5, and inhibition by heparin with IC(50)s of 0.9-1.5 ng/microL. We conclude that (1) the heparanase heterodimer (alpha/beta)(8)-TIM barrel fold is contributed by both 8 and 50 kDa subunits with the 6 kDa connecting fragment leading to inhibition of heparanase by possibly obstructing access to the active site, (2) proteolytic excision of the 6 kDa fragment is necessary and sufficient for heparanase activation, and (3) our findings open the way to the production of recombinant, constitutively active single-chain heparanase for structural studies and for the identification of inhibitors.
Similar articles
- Processing and activation of latent heparanase occurs in lysosomes.
Zetser A, Levy-Adam F, Kaplan V, Gingis-Velitski S, Bashenko Y, Schubert S, Flugelman MY, Vlodavsky I, Ilan N. Zetser A, et al. J Cell Sci. 2004 May 1;117(Pt 11):2249-58. doi: 10.1242/jcs.01068. J Cell Sci. 2004. PMID: 15126626 - Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells.
McKenzie E, Young K, Hircock M, Bennett J, Bhaman M, Felix R, Turner P, Stamps A, McMillan D, Saville G, Ng S, Mason S, Snell D, Schofield D, Gong H, Townsend R, Gallagher J, Page M, Parekh R, Stubberfield C. McKenzie E, et al. Biochem J. 2003 Jul 15;373(Pt 2):423-35. doi: 10.1042/BJ20030318. Biochem J. 2003. PMID: 12713442 Free PMC article. - Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, Pecker I. Vlodavsky I, et al. Nat Med. 1999 Jul;5(7):793-802. doi: 10.1038/10518. Nat Med. 1999. PMID: 10395325 - Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
Vlodavsky I, Elkin M, Pappo O, Aingorn H, Atzmon R, Ishai-Michaeli R, Aviv A, Pecker I, Friedmann Y. Vlodavsky I, et al. Isr Med Assoc J. 2000 Jul;2 Suppl:37-45. Isr Med Assoc J. 2000. PMID: 10909416 Review. - Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N, Elkin M, Vlodavsky I. Ilan N, et al. Int J Biochem Cell Biol. 2006;38(12):2018-39. doi: 10.1016/j.biocel.2006.06.004. Epub 2006 Jul 6. Int J Biochem Cell Biol. 2006. PMID: 16901744 Review.
Cited by
- Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.
Purushothaman A, Chen L, Yang Y, Sanderson RD. Purushothaman A, et al. J Biol Chem. 2008 Nov 21;283(47):32628-36. doi: 10.1074/jbc.M806266200. Epub 2008 Sep 23. J Biol Chem. 2008. PMID: 18812315 Free PMC article. - Forty Years of Basic and Translational Heparanase Research.
Vlodavsky I, Ilan N, Sanderson RD. Vlodavsky I, et al. Adv Exp Med Biol. 2020;1221:3-59. doi: 10.1007/978-3-030-34521-1_1. Adv Exp Med Biol. 2020. PMID: 32274705 Free PMC article. Review. - A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.
Zhao J, Wang W, Yuan Z, Jia R, Zhao Z, Xu X, Lv P, Zhang Y, Jiang C, Gao XM. Zhao J, et al. Virology. 2007 Mar 15;359(2):362-70. doi: 10.1016/j.virol.2006.09.022. Epub 2006 Oct 20. Virology. 2007. PMID: 17055551 Free PMC article. - Design Principle of Heparanase Inhibitors: A Combined In Vitro and In Silico Study.
Zhang Y, Xiong M, Chen Z, Seabra G, Liu J, Li C, Cui L. Zhang Y, et al. ACS Med Chem Lett. 2024 May 23;15(7):1032-1040. doi: 10.1021/acsmedchemlett.3c00268. eCollection 2024 Jul 11. ACS Med Chem Lett. 2024. PMID: 39015272 - Structural characterization of human heparanase reveals insights into substrate recognition.
Wu L, Viola CM, Brzozowski AM, Davies GJ. Wu L, et al. Nat Struct Mol Biol. 2015 Dec;22(12):1016-22. doi: 10.1038/nsmb.3136. Epub 2015 Nov 16. Nat Struct Mol Biol. 2015. PMID: 26575439 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources